Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Caribou Biosciences (CRBU) Return on Capital Employed (2021 - 2025)

Caribou Biosciences has reported Return on Capital Employed over the past 5 years, most recently at 92.85% for Q4 2025.

  • Quarterly Return on Capital Employed fell 3697.0% to 92.85% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 92.85% through Dec 2025, down 3697.0% year-over-year, with the annual reading at 67.76% for FY2025, 1906.0% down from the prior year.
  • Return on Capital Employed was 92.85% for Q4 2025 at Caribou Biosciences, down from 88.26% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 15.99% in Q4 2021 and troughed at 92.85% in Q4 2025.
  • The 5-year median for Return on Capital Employed is 34.26% (2024), against an average of 42.35%.
  • Year-over-year, Return on Capital Employed soared 185bps in 2023 and then plummeted -3766bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 15.99% in 2021, then tumbled by -86bps to 29.71% in 2022, then rose by 6bps to 27.86% in 2023, then plummeted by -101bps to 55.88% in 2024, then tumbled by -66bps to 92.85% in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Return on Capital Employed are 92.85% (Q4 2025), 88.26% (Q3 2025), and 76.74% (Q2 2025).